Close Menu

A Misunderstanding

At Patent Docs, Harold Wegner, a partner at the law firm Foley & Lardner, says that the popular idea that patenting "preempts follow-on research" and inhibits innovation is wrong and based on a flawed understanding of what patents are for. "A central axiom of any patent system is that the public has an immediate right on publication of a patent to experiment on newly patented technology," Wegner says. "This is precisely to encourage follow-on innovation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.